Skip to main content
. 2018 Mar 27;6:e4522. doi: 10.7717/peerj.4522

Table 3. Summary of previous studies from different regions about NDRD in diabetic patients.

The table shows different spectrum of NDRD in diabetic patients among other regions during 2011–2016.

Duration Number of patients DN NDRD NDRD + DN Most common NDRD
2011 Korea 1988–2008 119 T2DM 43 (36.1%) 64 (53.8%) 12 (10.1%) MN
2012 Malaysia 2004–2008 110 T2DM 69 (62.7%) 20 (18.2%) 21 (19.1%) AIN
2013 China 2003–2010 216 T2DM 14 (6.5%) 179 (82.9%) 23 (10.7%) IgAN
2013 China 2003–2011 244 T2DM 20 (8.2%) 205 (84%) 19 (7.8%) IgAN
2013 Korea 2000–2011 110 T2DM 41 (37.3%) 59 (53.6%) 10 (9.1%) IgAN
2013 USA 2011 620 T2DM 227 (37%) 220 (36%) 164 (27%) FSGS
2014 Croatia 2004–2013 80 T2DM 37 (46.25%) 29 (36.25%) 14 (17.5%) MN
2014 New Zealand 2004–2006 93 T2DM 30 (32%) 17 (18%) 46 (49%) FSGS
2016 China 2000–2015 273 T2DM 68 (24.9%) 175 (64.1%) 30 (11.0%) MN

Notes.

Values are expressed as frequencies and percentages (n(%)).

NDRD
non-diabetic renal disease
DN
diabetic nephropathy
MN
membraneous nephropathy
AIN
acute interstitial nephritis
IgAN
IgA nephropathy
FSGS
focal segmental glomerulosclerosis